RuvBL2 Is Involved in Histone Deacetylase Inhibitor PCI-24781-Induced Cell Death in SK-N-DZ Neuroblastoma Cells

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Zhan, Qinglei ^a   Tsai, Sauna ^a   Lu, Yonghai ^a   Wang, Chunmei ^a   Kwan, Yiuwa ^b   Ngai, Saiming ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ABEXINOSTAT; CASPASE 3; DEATH RECEPTOR 4; PROHIBITIN; PROTEIN HHR23A; PROTEIN P21; PROTEIN P53; PROTEIN PDCD6IP; PROTEIN RUVBL2; PROTEIN TRAP1; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL PROLIFERATION; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DOSE INCREASE; GENE SILENCING; HS 68 CELL INE; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUROBLASTOMA CELL; PROTEIN EXPRESSION; PROTEOMICS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; TUMOR GROWTH; UPREGULATION; WESTERN BLOTTING;

ACETYLATION; APOPTOSIS; BENZOFURANS; BLOTTING, WESTERN; CARRIER PROTEINS; CELL LINE, TUMOR; DNA HELICASES; G2 PHASE CELL CYCLE CHECKPOINTS; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; HYDROXAMIC ACIDS; MALE; MITOSIS; MODELS, BIOLOGICAL; NEOPLASM PROTEINS; NEUROBLASTOMA; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION;

EID: 84882667367     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071663     Document Type: Article

References (54)

1. Brodeur GM, (2003) Neuroblastoma: Biological insights into a clinical enigma. Nat Rev Cancer 3: 203-216.
2. Maris JM, (2010) Medical Progress: Recent Advances in Neuroblastoma. N Engl J Med 362: 2202-2211.
3. Janoueix-Lerosey I, Schleiermacher G, Michels E, Mosseri V, Ribeiro A, et al. (2009) Overall Genomic Pattern Is a Predictor of Outcome in Neuroblastoma. J Clin Oncol 27: 1026-1033.
4. Maris JM, Hogarty MD, Bagatell R, Cohn SL, (2007) Neuroblastoma. Lancet 369: 2106-2120.
5. Insinga A, Monestiroli S, Ronzoni S, Gelmetti V, Marchesi F, et al. (2005) Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of the death receptor pathway. Nat Med 11: 71-76.
6. Minucci S, Pelicci PG, (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6: 38-51.
7. Cedar H, Bergman Y, (2009) Linking DNA methylation and histone modification: patterns and paradigms. Nat Rev Genet 10: 295-304.
8. Egger G, Liang GN, Aparicio A, Jones PA, (2004) Epigenetics in human disease and prospects for epigenetic therapy. Nature 429: 457-463.
9. Esteller M, (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298.
10. Smith KT, Workman JL, (2009) Histone deacetylase inhibitors: Anticancer compounds. Int J Biochem Cell Biol 41: 21-25.
11. Mann BS, Johnson JR, Cohen MH, Justice R, Pazdur R, (2007) FDA approval summary: Vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. Oncologist 12: 1247-1252.
12. Li Y, Kao GD, Garcia BA, Shabanowitz J, Hunt DF, et al. (2006) A novel histone deacetylase pathway regulates mitosis by modulating Aurora B kinase activity. Genes Dev 20: 2566-2579.
13. Hrzenjak A, Kremser ML, Strohmeier B, Moinfar F, Zatloukal K, et al. (2008) SAHA induces caspase-independent, autophagic cell death of endometrial stromal sarcoma cells by influencing the mTOR pathway. J Pathol 216: 495-504.
14. Cayo MA, Cayo AK, Jarjour SM, Chen H, (2009) Sodium butyrate activates Notch1 signaling, reduces tumor markers, and induces cell cycle arrest and apoptosis in pheochromocytoma. Am J Transl Res 1: 178-183.
15. Rivera-Del Valle N, Gao S, Miller CP, Fulbright J, Gonzales C, et al. (2010) PCI-24781, a Novel Hydroxamic Acid HDAC Inhibitor, Exerts Cytotoxicity and Histone Alterations via Caspase-8 and FADD in Leukemia Cells. Int J Cell Biol 2010: 207420-207420.
16. Wiegmans AP, Alsop AE, Bots M, Cluse LA, Williams SP, et al. (2011) Deciphering the Molecular Events Necessary for Synergistic Tumor Cell Apoptosis Mediated by the Histone Deacetylase Inhibitor Vorinostat and the BH3 Mimetic ABT-737. Cancer Res 71: 3603-3615.
17. Coffey DC, Kutko MC, Glick RD, Swendeman SL, Butler L, et al. (2000) Histone deacetylase inhibitors and retinoic acids inhibit growth of human neuroblastoma in vitro. Med Pediatr Oncol 35: 577-581.
18. Tang XX, Robinson ME, Riceberg JS, Kim DY, Kung B, et al. (2004) Favorable neuroblastoma genes and molecular therapeutics of neuroblastoma. Clin Cancer Res 10: 5837-5844.
19. Muehlethaler-Mottet A, Meier R, Flahaut M, Bourloud KB, Nardou K, et al. (2008) Complex molecular mechanisms cooperate to mediate histone deacetylase inhibitors anti-tumour activity in neuroblastoma cells. Mol Cancer 7: 55-66.
20. Ouwehand K, de Ruijter AJM, van Bree C, Caron HN, van Kuilenburg ABP, (2005) Histone deacetylase inhibitor BL1521 induces a G1-phase arrest in neuroblastoma cells through altered expression of cell cycle proteins. FEBS Lett 579: 1523-1528.
21. Francisco R, Perez-Perarnau A, Cortes C, Gil J, Tauler A, et al. (2012) Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells. Cancer Lett 318: 42-52.
22. Coffey DC, Kutko MC, Glick RD, Butler LM, Heller G, et al. (2001) The histone deacetylase inhibitor, CBHA, inhibits growth of human neuroblastoma xenografts in vivo, alone and synergistically with all-trans retinoic acid. Cancer Res 61: 3591-3594.
23. Shah RD, Jagtap JC, Mruthyunjaya S, Shelke GV, Pujari R, et al. (2012) Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition. J Cell Biochem 114: 854-863.
24. Wanczyk M, Roszczenko K, Marcinkiewicz K, Bojarczuk K, Kowara M, et al. (2011) HDACi- going through the mechanisms. Front Biosci 16: 340-359.
25. Subramanian C, Opipari AW, Bian X, Castle VP, Kwok RPS, (2005) Ku70 acetylation mediates neuroblastoma cell death induced by histone deacetylase inhibitors. Proc Natl Acad Sci U S A 102: 4842-4847.
26. Subramanian C, Jarzembowski JA, Opipari AW Jr, Castle VP, Kwok RPS, (2011) HDAC6 Deacetylates Ku70 and Regulates Ku70-Bax Binding in Neuroblastoma. Neoplasia 13: 726-734.
27. More SS, Itsara M, Yang X, Geier EG, Tadano MK, et al. (2011) Vorinostat Increases Expression of Functional Norepinephrine Transporter in Neuroblastoma In Vitro and In Vivo Model Systems. Clin Cancer Res 17: 2339-2349.
28. Buggy JJ, Cao ZA, Bass KE, Verner E, Balasubramanian S, et al. (2006) CRA-024781: a novel synthetic inhibitor of histone deacetylase enzymes with antitumor activity in vitro and in vivo. Mol Cancer Ther 5: 1309-1317.
29. Rodriguez-Collazo P, Leuba SH, Zlatanova J, (2009) Robust methods for purification of histones from cultured mammalian cells with the preservation of their native modifications. Nucleic Acids Res 37: 11-25.
30. Loprevite M, Tiseo M, Grossi F, Scolaro T, Semino C, et al. (2005) In vitro study of CI-994, a histone deacetylase inhibitor, in non-small cell lung cancer cell lines. Oncol Res 15: 39-48.
31. Johnstone RW, (2002) Histone-deacetylase inhibitors: Novel drugs for the treatment of cancer. Nat Rev Drug Discov 1: 287-299.
32. Grimwood J, Gordon LA, Olsen A, Terry A, Schmutz J, et al. (2004) The DNA sequence and biology of human chromosome 19. Nature 428: 529-535.
33. Jha S, Dutta A, (2009) RVB1/RVB2: Running Rings around Molecular Biology. Mol Cell 34: 521-533.
34. Hua G, Zhang Q, Fan Z, (2007) Heat shock protein 75 (TRAP1) antagonizes reactive oxygen species generation and protects cells from granzyme M-mediated apoptosis. J Biol Chem 282: 20553-20560.
35. Chatellard-Causse C, Blot B, Cristina N, Torch S, Missotten M, et al. (2002) Alix (ALG-2-interacting protein X), a protein involved in apoptosis, binds to endophilins and induces cytoplasmic vacuolization. J Biol Chem 277: 29108-29115.
36. Adimoolam S, Sirisawad M, Chen J, Thiemann P, Ford JM, et al. (2007) HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination. Proc Natl Acad Sci U S A 104: 19482-19487.
37. Chakrabarti M, Banik NL, SK R (2013) Sequential hTERT Knockdown and Apigenin Treatment Inhibited Invasion and Proliferation and Induced Apoptosis in Human Malignant Neuroblastoma SK-N-DZ and SK-N-BE2 Cells. J Mol Neurosci 10.1007/s12031-013-9975-x.
38. Jaboin J, Wild J, Hamidi H, Khanna C, Kim CJ, et al. (2002) MS-27-275, an inhibitor of histone deacetylase, has marked in vitro and in vivo antitumor activity against pediatric solid tumors. Cancer Res 62: 6108-6115.
39. Xu WS, Parmigiani RB, Marks PA, (2007) Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 26: 5541-5552.
40. Bhalla S, Balasubramanian S, David K, Sirisawad M, Buggy J, et al. (2009) PCI-24781 Induces Caspase and Reactive Oxygen Species-Dependent Apoptosis Through NF-kappa B Mechanisms and Is Synergistic with Bortezomib in Lymphoma Cells. Clin Cancer Res 15: 3354-3365.
41. Lopez G, Liu J, Ren W, Wei W, Wang S, et al. (2009) Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, with Chemotherapy for the Treatment of Soft Tissue Sarcoma. Clin Cancer Res 15: 3472-3483.
42. Abbas T, Dutta A, (2009) p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 9: 400-414.
43. Qiu L, Burgess A, Fairlie DP, Leonard H, Parsons PG, et al. (2000) Histone deacetylase inhibitors trigger a G2 checkpoint in normal cells that is defective in tumor cells. Mol Biol Cell 11: 2069-2083.
44. Li J, Liu R, Lei Y, Wang K, Lau QC, et al. (2010) Proteomic analysis revealed association of aberrant ROS signaling with suberoylanilide hydroxamic acid-induced autophagy in Jurkat T-leukemia cells. Autophagy 6: 711-724.
45. Theiss AL, Sitaraman SV, (2011) The role and therapeutic potential of prohibitin in disease. Biochim Biophys Acta 1813: 1137-1143.
46. Wang S, Fusaro G, Padmanabhan J, Chellappan SP, (2002) Prohibitin co-localizes with Rb in the nucleus and recruits N-CoR and HDAC1 for transcriptional repression. Oncogene 21: 8388-8396.
47. Yang Y, Rao R, Shen J, Tang Y, Fiskus W, et al. (2008) Role of acetylation and extracellular location of heat shock protein 90 alpha in tumor cell invasion. Cancer Res 68: 4833-4842.
48. Rao R, Nalluri S, Kolhe R, Yang Y, Fiskus W, et al. (2010) Treatment with Panobinostat Induces Glucose-Regulated Protein 78 Acetylation and Endoplasmic Reticulum Stress in Breast Cancer Cells. Mol Cancer Ther 9: 942-952.
49. Chen G, Li A, Zhao M, Gao Y, Zhou T, et al. (2008) Proteomic analysis identifies protein targets responsible for depsipeptide sensitivity in tumor cells. J Proteome Res 7: 2733-2742.
50. Tong A, Zhang H, Li Z, Gou L, Wang Z, et al. (2008) Proteomic analysis of liver cancer cells treated with suberonylanilide hydroxamic acid. Cancer Chemother Pharmacol 61: 791-802.
51. Dantuma NP, Heinen C, Hoogstraten D, (2009) The ubiquitin receptor Rad23: At the crossroads of nucleotide excision repair and proteasomal degradation. DNA Repair 8: 449-460.
52. Venteicher AS, Meng Z, Mason PJ, Veenstra TD, Artandi SE, (2008) Identification of ATPases pontin and reptin as telomerase components essential for holoenzyme assembly. Cell 132: 945-957.
53. Jha S, Gupta A, Dar A, Dutta A, (2013) RVBs Are Required for Assembling a Functional TIP60 Complex. Mol Cell Biol 33: 1164-1174.
54. Gospodinov A, Tsaneva I, Anachkova B, (2009) RAD51 foci formation in response to DNA damage is modulated by TIP49. Int J Biochem Cell Biol 41: 925-933.